0001493152-21-022217.txt : 20210908
0001493152-21-022217.hdr.sgml : 20210908
20210908170037
ACCESSION NUMBER: 0001493152-21-022217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210903
FILED AS OF DATE: 20210908
DATE AS OF CHANGE: 20210908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saund Saran
CENTRAL INDEX KEY: 0001834417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21990
FILM NUMBER: 211242765
MAIL ADDRESS:
STREET 1: C/O MATEON THERAPEUTICS INC.
STREET 2: 29397 AGOURA RD SUTIE 107
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncotelic Therapeutics, Inc.
CENTRAL INDEX KEY: 0000908259
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133679168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29397 AGOURA RD.
STREET 2: #107
CITY: AGUORA HILLS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 650-635-7000
MAIL ADDRESS:
STREET 1: 29397 AGOURA RD.
STREET 2: #107
CITY: AGUORA HILLS
STATE: CA
ZIP: 91301
FORMER COMPANY:
FORMER CONFORMED NAME: MATEON THERAPEUTICS INC
DATE OF NAME CHANGE: 20160613
FORMER COMPANY:
FORMER CONFORMED NAME: OXIGENE INC
DATE OF NAME CHANGE: 19930628
4
1
ownership.xml
X0306
4
2021-09-03
0
0000908259
Oncotelic Therapeutics, Inc.
OTLC
0001834417
Saund Saran
29397 AGOURA RD SUITE 107
AGOURA HILLS,
CA
91301
0
1
0
0
Chief Business Officer
Stock Options
0.1393
2021-09-03
4
A
0
675000
0
A
2031-09-03
Common Stock
675000
675000
D
Stock Options vest as follows: (i) 50% of the options will vest upon the consummation of a qualifying joint venture agreement, licensing agreement, or acquisition transaction (a "Corporate Transaction"); (ii) The remaining 50% on the one-year anniversary of the consummation of a Corporate Transaction.
/s/ Saran Saund
2021-09-08